高盛:維持瑞聲科技(2018.HK)買入評級 目標價66港元
高盛發表研究報吿指,即使瑞聲科技(2018.HK)發佈了第三季度的盈利預警,管理層仍對第四季維持樂觀,主要由於更多新Android手機型號推出,尤其是旗艦型號,而瑞聲將會在芯片短缺情況下,以提升其毛利率為優先目標。該行維持其“買入”評級,目標價66港元。
該行指,第三季發盈警主要由於部分美國客户的訂單屬季節性及第三季有一次性成本,例如越南工廠於新冠疫情期間的增量成本,同時已反映在毛利率中。
該行認為,儘管智能手機市場需求變幻莫測,對行業的樂觀看法不變,該行認為公司的新業務如手機鏡頭正在擴張,未來出貨量將有上行空間,公司未來亦將會擴展業務至汽車市場,其車載鏡頭產品將於1-2年後進入大規模生產。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.